About: Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1997 (uk) im April 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1997 (ast) scientific article published on 01 April 1997 (en)
publication date	wds:Q73260617-52E14B80-E0CE-40F6-A998-F9B062D74D71
publication date	1997-04-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73260617-B0BFD378-F081-40C2-9416-03A9DC745DAB wds:Q73260617-B327C96A-F2FB-4F3E-BCAB-0FBC28DA6465 wds:Q73260617-B56F9129-7A51-448D-ACD6-DDDE50E22193 wds:Q73260617-B5C192DE-8AFC-4B84-A94F-D4398AC05EE2 wds:Q73260617-BEF7C4FB-5CFA-4C56-B657-DC5EBAAA5F0E wds:Q73260617-C27FDD7C-70A1-4A4C-958F-2DBC64962B70
author name string	Hann IM Wheatley K Burnett AK Stevens RF Rees JK Gray RG
rdfs:label	Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (nl) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the (en)
skos:prefLabel	Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (nl) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the (en)
name	Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (nl) Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the (en)
author	wds:Q73260617-69651909-49DA-4F44-82FB-C9BE842FC306
author	Anthony H. Goldstone
title	wds:Q73260617-DF538380-F19E-4B3C-BEE0-BFF10D152F80
title	Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council (en)
page(s)	wds:Q73260617-BE241E65-1E2D-4826-95CA-9E13E49DBDFD
page(s)	2311-2318
instance of	wds:Q73260617-4AE16562-2A98-4D75-9062-5B599B9F783D
instance of	scholarly article
PubMed ID	wds:Q73260617-65243A7B-864A-46B2-BB7E-0930A070A9CF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9116274
PubMed ID	9116274
published in	wds:Q73260617-0729CEED-6559-4D78-92B2-A1B57FF34DFC
published in	Blood
issue	wds:Q73260617-00C3E827-AF22-43A2-9713-494E4884B249
volume	wds:Q73260617-F4975963-4057-42CF-988F-E5ECC2E05206
issue	7
volume	89
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73260617
is cites work of	Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report Age and acute myeloid leukemia FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group Trends in the treatment of acute myeloid leukaemia in the elderly. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia The effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophy Improved outcome of acute myeloid leukaemia in Down's syndrome Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States. Efficacy of acute myeloid leukemia therapy without stem-cell transplantation in a child with blastic plasmacytoid dendritic cell neoplasm. The evolving landscape in the therapy of acute myeloid leukemia Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells. Erythroleukaemia in the north of England: a population based study Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments Evidence based medicine Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative database Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation Childhood acute myeloid leukaemia Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation Pharmacoeconomic considerations in treating patients with acute leukaemia The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature. Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells Molecular targeting in acute myeloid leukemia Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients Randomised unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukaemia Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia
is cites work of	wds:Q35169597-74CA58F3-2F5F-418C-8C1F-B8A21324E0D7 wds:Q28484390-AB4797DA-C4FD-416B-98D5-BF82728F0103 wds:Q33662916-58110C6F-70E2-4C51-A348-82CEFCC98731 wds:Q38155455-FE20465E-CFCC-4AFF-B39F-FC125BBFE4B5 wds:Q35430146-F2BE6C1D-F361-418C-87E1-5E1BDD17F9C0 wds:Q77571485-4E0C763E-CC54-4088-84BA-5D7A24242829 wds:Q37267506-13754C51-28AB-4C59-A72E-7CBC8811130A wds:Q38132064-770E0D52-A455-4E84-BB3C-EFEB7383264E wds:Q36988021-C16128FD-2268-4E9C-A83B-D48EC1F7A424 wds:Q35215042-32318758-F83C-450B-A5E3-0DB33D81D02B wds:Q26799609-FD3C6729-5CA7-40B5-A346-B90BC4517BD5 wds:Q36934395-1322CB18-1549-446D-9581-93610A8CC1FC wds:Q35859437-B8846B48-5AF1-46F3-9D7E-BB57086C616C wds:Q36618262-61F361CC-4111-4734-9F65-2A8CE57BF1C2 wds:Q37396005-90294883-A7C0-4B76-8826-988AFC58DC09 wds:Q49840237-9B7B453D-E642-4841-A118-E3447DDDB0EA wds:Q89669586-EA02FAD5-ED88-4DA5-A940-E1C8AD326C9A wds:Q43156053-9C05E72C-19B8-4119-93A2-A0DC0D8ACFDB wds:Q39475017-EB14EC92-C4EB-42AC-B7FA-79CC03E2DEE8 wds:Q54301888-C8E51674-B3E9-4CFD-87F0-9259CD8CFE19 wds:Q51958946-63E47736-7B36-48B0-AE9D-662E6D1EE1C8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software